The Department of Health (LDH), which oversees Medicaid, has issued several updates for pharmacies. Links to those updates are below:
- Louisiana Medicaid Pharmacy Point of Sale (POS) Diagnosis Code Requirement for Select Medications – August 3, 2020
- Louisiana Medicaid Pharmacy Point of Sale (POS) Quantity Limits – August 3, 2020
- Louisiana Medicaid Pharmacy Point of Sale (POS) Edits for Lumateperone (Caplyta™) – August 3, 2020
- Louisiana Medicaid Pharmacy Point of Sale Clinical Authorization for Select Drugs – August 3, 2020
- Louisiana Medicaid Provider Updates
Also in Louisiana. LDH announced several extensions through October 31, 2020, due to COVID. Those extensions apply to:
- Existing approved prior authorizations on prescribed drugs and physician-administered drugs (drugs included as a medical benefit). According to LDH, this will not affect the number of refills originally authorized by the prescriber.
- Member copays for prescribed drugs, which will continue to be waived.
- A 90-day supply of appropriate maintenance medications that are not controlled substances. This includes cardiovascular drugs (hypertension, coronary artery disease, thrombosis), diabetes drugs, respiratory drugs (inhaled and oral), contraceptives, antivirals, direct-acting antivirals for hepatitis C, immunosuppressives, antipsychotics, and antidepressants, among others.
- Member signatures, which will not be required.
Also in Louisiana. The Board of Pharmacy will be holding a virtual full board meeting on Thursday, August 13, 2020. The full agenda can be found here.
Also in Louisiana. The Board of Pharmacy posted its new Pharmacy Law Book. The new law book can be found here.
For more information, contact NACDS’ Mary Staples at 817-442-1155.